2 U.S. Food & Drug Administration, Emergency Use Authorization of Medical Products and Related Authorities, (Jan 2017). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#preeua
3 Jonathan Saltzman, US Government Has Invested $6 Billion In Moderna’s COVID19 Vaccine, STAT News, (April 30th 2021). https://www.statnews.com/2021/04/30/u-s-government-has-invested-6-billion-in-modernas-covid-19-vaccine/https://www.statnews.com/2021/04/30/u-s-government-has-invested-6-billion-in-modernas-covid-19-vaccine/
4 Bob Herman, NIH-Moderna Confidential Disclosure Agreement, AXIOS, (Nov 6, 2015) https://www.documentcloud.org/documents/6935295-NIH-Moderna-Confidential-Agreements.html
5 Zain Rizvi, The NIH Vaccine, PUBLIC CITIZEN, (Jun 25, 2020). https://www.citizen.org/article/the-nih-vaccine/#_ftn2
6 Legal Information Institute, 15 U.S. Code § 3710c - Distribution of royalties received by Federal agencies, CORNELL LAW SCHOOL, https://www.law.cornell.edu/uscode/text/15/3710c
7 Marisa Taylor and Aram Roston, Pressed by Trump, U.S. pushed unproven coronavirus treatment guidance, REUTERS, (Apr 4, 2020). https://www.reuters.com/article/us-health-coronavirus-usa-guidance-exclu/exclusive-pressed-by-trump-u-s-pushed-unproven-coronavirus-treatment-guidance-idUSKBN21M0R2
8 World Health Organization, Unedited Report of the 18th Expert Committee on the Selection and Use of Essential Medicines, (Mar 21-25, 2011). https://www.who.int/selection_medicines/Complete_UNEDITED_TRS_18th.pdf?ua=1
9 Concordia Pharmaceuticals Inc, PLAQUENIL? HYDROXYCHLOROQUINE SULFATE TABLETS, USP, (Jan, 2017). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf
10 STELLA IMMANUEL, MD, LET AMERICA LIVE: EXPOSING THE HIDDEN AGENDA BEHIND THE 2020 PANDEMIC: MY JOURNEY, CH 1 (Charisma House 2021) 11 Centers for Disease Control and Prevention, Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil?), https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/hydroxychloroquine.pdf
12 Peter A. McCullough, MD, Why doctors and researchers need access to hydroxychloroquine, THE HILL, (Aug 7, 2020). https://thehill.com/opinion/healthcare/510700-why-doctors-and-researchers-need-access-to-hydroxychloroquine
13 Els Keyaerts et al, In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Oct 8, 2004).
14 Keyaerts, Els et al., In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Biochemical and biophysical research communications vol. 323,1 (2004): 264-8. doi:10.1016/j. bbrc.2004.08.085, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092815/pdf/main.pdf
15 Martin J. Vincent et al, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, (Aug 22, 2005). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/
16 Julie Dyall, et al, Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection, Volume 58 Issue 8, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 4885-93 (2014), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136000/
17 Adriaan H. de Wilde et al., Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, VOL 58 ISSUE 8, ASM JOURNALS ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 4875-4884 (2014), https://doi.org/10.1128/AAC.03011-14
18 Yi Su et al, Efficacy of early hydroxychloroquine treatment in preventing COVID19 pneumonia aggravation, the experience from Shanghai, China, BIOSCIENCE TRENDS, (Jan 23, 2021). https://pubmed.ncbi.nlm.nih.gov/33342929/
19 Jean-Christophe Lagier et al, Outcomes of 3,737 COVID19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, TRAVEL MEDICINE AND INFECTIOUS DISEASE, (Jul-Aug, 2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315163/
20 Saja H. Almazrou et al, Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID19 patient outcomes: A retrospective cohort study, SAUDI PHARMACEUTICAL JOURNAL, (Dec 2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527306/
21 Majid Mokhtaria et al, Clinical outcomes of patients with mild COVID19 following treatment with hydroxychloroquine in an outpatient setting, INTERNATIONAL IMMUNOPHARMACOLOGY, (July, 2021). https://www.sciencedirect.com/science/article/pii/S1567576921002721
22 The COVID19 RISK and Treatments (CORIST) Collaboration, Use of hydroxychloroquine in hospitalised COVID19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study, EUROPEAN JOURNAL OF INTERNAL MEDICINE, (Dec 1, 2020). https://www.ejinme.com/article/S0953-6205(20)30335-6/fulltext
23 Awadhesh Kumar Singh et al, Chloroquine and hydroxychloroquine in the treatment of COVID19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries, DIABETES & METABOLIC SYNDROME: CLINICAL RESEARCH AND REVIEWS, (May-Jun, 2020). https://www.sciencedirect.com/science/article/abs/pii/S1871402120300515#!
24 Alyssa Paolicelli, Drug Combo with Hydroxychloroquine Promising: NYU Study, SPECTRUM NEWS NY1 (May 20, 2021, 7:18 AM), https://www.ny1.com/nyc/all-boroughs/news/2020/05/12/nyu-study-looks-at-hydroxychloroquine-zinc-azithromycin-combo-on-decreasing-covid19-deaths
25 Roland Derwand, Martin Scholz and Vladimir Zelenko, COVID19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, (Dec 2020). https://pubmed.ncbi.nlm.nih.gov/33122096/
26 Samia Arshad, Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID19, INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, (Aug 2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330574/
27 Fabricio Souza Neves, Correlation of the rise and fall in COVID19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis, TRAVEL MEDICINE AND INFECTIOUS DISEASE, (May-Jun, 2021). https://pubmed.ncbi.nlm.nih.gov/33667717/
28 Didier Raoult et al, Hydroxychloroquine and azithromycin as a treatment of COVID19: results of an open-label non-randomized clinical trial, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, (Jul 2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102549/
29 Roland Derwand, Martin Scholz and Vladimir Zelenko, COVID19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, (Dec 2020). https://pubmed.ncbi.nlm.nih.gov/33122096/